Don’t invest unless you’re prepared to lose all your money. These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more
 
7 Bell Yard, London, WC2A 2JR
enquiries@norcliffe.capital
Open Investment Opportunities
 

About

We are a young, focused company offering investments with impact
bt_bb_section_bottom_section_coverage_image

We are
Norcliffe Capital

With several decades of combined business experience in the life science sectors, Norcliffe Capital provides more than capital to support our investments.

We use our experience and expertise to select UK based growth companies in our specialist sectors and support them throughout their commercial journey.

Operating across the UK, we source companies with proven IP aiming to make a material impact in their industry, within a growing global market, where there is a clearly defined consumer need. Our investments are usually uncorrelated to the traditional investment markets and have a range of exit routes which offer the potential of generating positive investor returns.

Norcliffe Capital works with financial advisers, wealth managers, family offices, private banks, accountants and individuals who are looking to directly invest in innovative UK companies within the life science sectors with the potential to achieve exponential growth. Norcliffe Capital offers tax efficient ways to invest via the Enterprise Investment Scheme (EIS), SIPP, SSAS or a family investment company, as well as on a direct equity basis.

2015

Norcliffe Capital established

New office in Cheshire

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2016

Orsus Medical seed fundraise

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2017

Orsus Medical pre-series A fundraise

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2018

February 2018

Norcliffe Capital is incorporated

November 2018

Norcliffe becomes an appointed representative of Sturgeon Ventures LLP

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2019

New office in East Sussex

Professor David Onions joins the team

Wi-Fi Securities seed fundraise

Afon Technology seed fundraise

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2020

Wi-Fi Securities pre-series A fundraise

Biosceptre International series A fundraise

Afon Technology pre-series A fundraise

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2021

ClinSpec Diagnostics fundraise

Afon Technology series A fundraise

Wi-Fi Securities fundraise

Aureum Diagnostics seed fundraise

SMi Drug Discovery seed fundraise

New office in London

TOTAL FUNDRAISE £31.4 MILLION

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2015

Norcliffe Capital established

New office in Cheshire

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2016

Orsus Medical seed fundraise

NeedleSmart seed fundraise

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2017

Orsus Medical pre-series A fundraise

NeedleSmart pre-series A fundraise

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2018

February 2018

Norcliffe Capital is incorporated

NeedleSmart series A fundraise

November 2018

Norcliffe becomes an appointed representative of Sturgeon Ventures LLP

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2019

New office in East Sussex

Professor David Onions joins the team

Wi-Fi Securities seed fundraise

NeedleSmart series B fundraise

Afon Technology seed fundraise

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2020

Wi-Fi Securities pre-series A fundraise

Biosceptre International series A fundraise

Afon Technology pre-series A fundraise

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]

2021

ClinSpec Diagnostics fundraise

Afon Technology series A fundraise

Wi-Fi Securities fundraise

Aureum Diagnostics seed fundraise

SMi Drug Discovery seed fundraise

New office in London

TOTAL FUNDRAISE £31.4 MILLION

[bold_timeline_item_button title=”Expand” style=”” shape=”” color=”” size=”inline” url=”#” el_class=”bold_timeline_group_button”]
https://www.norcliffe.capital/wp-content/uploads/2023/03/timeline.jpg
https://www.norcliffe.capital/wp-content/uploads/2023/03/abount-timeline-replace.png
SELECT
We are highly selective and undertake rigorous due diligence before proceeding to invest.
90%
Financing Options
85%
Financing Solutions
https://www.norcliffe.capital/wp-content/uploads/2020/08/floating_image_03.png
https://www.norcliffe.capital/wp-content/uploads/2020/08/floating_image_05.png

We have a strict investment mandate

Norcliffe Capital offers the opportunity to invest directly in private companies in the life science sectors
Read Our Mandate
bt_bb_section_top_section_coverage_image
bt_bb_section_bottom_section_coverage_image
https://www.norcliffe.capital/wp-content/uploads/2020/08/floating_image_04.png
https://www.norcliffe.capital/wp-content/uploads/2021/04/approach.png

Our Approach

Providing direct investment in ground-breaking MedTech and BioTech companies.

With decades of combined business experience in the life science sectors, Norcliffe Capital provides more than capital to support our investments. We use our experience and expertise to select UK based growth companies in our specialist sectors and support them throughout their commercial journey.

We source companies with proven IP aiming to make a material impact in their industry. Our investments are usually uncorrelated to the traditional investment markets and have a range of exit routes to generate positive investor returns.

bt_bb_section_top_section_coverage_image

Our Team

We combine global expertise and local insight to help you
https://www.norcliffe.capital/wp-content/uploads/2021/04/patricia-ceo-norcliffe.jpg
As a venture capital firm specialising in medtech and biotech, we have the privilege of supporting the future of life science technology. Our investments are driven by a mission to make a meaningful impact on healthcare, whether it's improving patient outcomes, reducing costs, or saving lives. It's been truly eye-opening to witness the incredible talent and innovation of UK scientists and business leaders in the medtech, biotech and pharmaceutical sectors. Each year we come across hundreds of outstanding innovations, and we meticulously choose the ones that have the potential to revolutionise healthcare for our investment portfolio.
Patricia Reynolds, CEO
It is such a privilege to support the next generation of life science technology. Our investments focus on meaningful causes that enhance the healthcare journey, save costs or save lives. Having more insight into medtech, biotech and pharmaceutical developments over the past few years has been an eye opener and revealed how truly talented our UK scientists and business leaders are. We see hundreds of outstanding innovations each year and carefully select those to join our portfolio of investments.
Patricia Reynolds, CEO

Norcliffe Capital team is a diverse network of consultants and industry professionals with a global mindset and a collaborative culture. We work to understand your issues and are driven to ask better questions in the pursuit of making your business work better.

bt_bb_section_top_section_coverage_image
bt_bb_section_bottom_section_coverage_image

Subscribe to our Newsletter

    Subscribe to our Newsletter

      https://www.norcliffe.capital/wp-content/uploads/2021/03/NC-Standard-GOLD-V2.png

      Quick Links

      Investments

      Connect

      Norcliffe Capital Ltd FRN # 826977 who is an Appointed Representative of Sturgeon Ventures LLP who is authorised and regulated by the Financial Conduct Authority FRN # 452811.

      https://www.norcliffe.capital/wp-content/uploads/2022/02/Member-of-EISA.png
      7 Bell Yard, London, WC2A 2JR
      7 Bell Yard, London, WC2A 2JR
      enquiries@norcliffe.capital
      0203 745 0653

      COPYRIGHT @2022 NORCLIFFE CAPITAL. ALL RIGHTS RESERVED.

      IMPORTANT INFORMATION

       

      Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk. 

      What are the key risks? 

      1. You could lose all the money you invest
        • If the business you invest in fails, you are likely to lose 100% of the money you invested. Most start-up businesses fail. 
      1. You are unlikely to be protected if something goes wrong
        • Protection from the Financial Services Compensation Scheme (FSCS), in relation to claims against failed regulated firms, does not cover poor investment performance. Try the FSCS investment protection checker here.  
        • Protection from the Financial Ombudsman Service (FOS) does not cover poor investment performance. If you have a complaint against an FCA-regulated firm, FOS may be able to consider it. Learn more about FOS protection here.  
      1. You won’t get your money back quickly
        • Even if the business you invest in is successful, it may take several years to get your money back. You are unlikely to be able to sell your investment early. 
        • The most likely way to get your money back is if the business is bought by another business or lists its shares on an exchange such as the London Stock Exchange. These events are not common. 
        • If you are investing in a start-up business, you should not expect to get your money back through dividends. Start-up businesses rarely pay these. 
      1. Don’t put all your eggs in one basket
        • Putting all your money into a single business or type of investment for example, is risky. Spreading your money across different investments makes you less dependent on any one to do well. 
        • A good rule of thumb is not to invest more than 10% of your money in high-risk investments.  
      1. The value of your investment can be reduced
        • The percentage of the business that you own will decrease if the business issues more shares. This could mean that the value of your investment reduces, depending on how much the business grows.  Most start-up businesses issue multiple rounds of shares. 
        • These new shares could have additional rights that your shares don’t have, such as the right to receive a fixed dividend, which could further reduce your chances of getting a return on your investment.  

      If you are interested in learning more about how to protect yourself, visit the FCA’s website here.  

      Privacy settings

      Decide which cookies you want to allow. You can change these settings at any time. However, this can result in some functions no longer being available. For information on deleting the cookies, please consult your browser’s help function. Learn more about the cookies we use.

      With the slider, you can enable or disable different types of cookies:

      • Block all
      • Essentials
      • Functionality
      • Analytics
      • Advertising

      This website will:

      • Essential: Remember your cookie permission setting
      • Essential: Allow session cookies
      • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
      • Essential: Keep track of what you input in a shopping cart
      • Essential: Authenticate that you are logged into your user account
      • Essential: Remember language version you selected

      This website won't:

      • Remember your login details
      • Functionality: Remember social media settings
      • Functionality: Remember selected region and country
      • Analytics: Keep track of your visited pages and interaction taken
      • Analytics: Keep track about your location and region based on your IP number
      • Analytics: Keep track of the time spent on each page
      • Analytics: Increase the data quality of the statistics functions
      • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
      • Advertising: Gather personally identifiable information such as name and location

      This website will:

      • Essential: Remember your cookie permission setting
      • Essential: Allow session cookies
      • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
      • Essential: Keep track of what you input in a shopping cart
      • Essential: Authenticate that you are logged into your user account
      • Essential: Remember language version you selected
      • Functionality: Remember social media settings
      • Functionality: Remember selected region and country

      This website won't:

      • Remember your login details
      • Analytics: Keep track of your visited pages and interaction taken
      • Analytics: Keep track about your location and region based on your IP number
      • Analytics: Keep track of the time spent on each page
      • Analytics: Increase the data quality of the statistics functions
      • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
      • Advertising: Gather personally identifiable information such as name and location

      This website will:

      • Essential: Remember your cookie permission setting
      • Essential: Allow session cookies
      • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
      • Essential: Keep track of what you input in a shopping cart
      • Essential: Authenticate that you are logged into your user account
      • Essential: Remember language version you selected
      • Functionality: Remember social media settingsl Functionality: Remember selected region and country
      • Analytics: Keep track of your visited pages and interaction taken
      • Analytics: Keep track about your location and region based on your IP number
      • Analytics: Keep track of the time spent on each page
      • Analytics: Increase the data quality of the statistics functions

      This website won't:

      • Remember your login details
      • Advertising: Use information for tailored advertising with third parties
      • Advertising: Allow you to connect to social sites
      • Advertising: Identify device you are using
      • Advertising: Gather personally identifiable information such as name and location

      This website will:

      • Essential: Remember your cookie permission setting
      • Essential: Allow session cookies
      • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
      • Essential: Keep track of what you input in a shopping cart
      • Essential: Authenticate that you are logged into your user account
      • Essential: Remember language version you selected
      • Functionality: Remember social media settingsl Functionality: Remember selected region and country
      • Analytics: Keep track of your visited pages and interaction taken
      • Analytics: Keep track about your location and region based on your IP number
      • Analytics: Keep track of the time spent on each page
      • Analytics: Increase the data quality of the statistics functions
      • Advertising: Use information for tailored advertising with third parties
      • Advertising: Allow you to connect to social sitesl Advertising: Identify device you are using
      • Advertising: Gather personally identifiable information such as name and location

      This website won't:

      • Remember your login details
      Save & Close